Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers

Area of Science:

• Oncology
• Epigenetics
• Genomics

Background:

• Isocitrate dehydrogenase (IDH1/2) mutations are early drivers in various human cancers.
• IDH1/2 mutations are known to induce a global hypermethylator phenotype, but their precise impact on DNA methylation across different cancer types and genomic regions is not fully understood.

Purpose of the Study:

• To investigate the genome-wide DNA methylation patterns in IDH1/2 mutant cancers.
• To determine how DNA methylation is affected across functionally distinct genomic regions (promoters, gene bodies, enhancers) and chromosomal locations in IDH1/2 mutant cancers.

Main Methods:

• Analysis of DNA methylation data from a cohort of IDH1/2 mutant cancers including acute myeloid leukemia, oligodendroglioma, astrocytoma, breast carcinoma, sinonasal undifferentiated carcinoma, and cholangiocarcinoma.
• Clustering of cancer types based on embryonal origin to identify common methylation patterns.

Main Results:

• IDH1/2 mutations lead to global DNA hypermethylation, predominantly affecting gene bodies and enhancers.
• Promoters in IDH1/2 mutant cancers generally remain unmethylated.
• Specific chromosomes, arms, and regions exhibit differential susceptibility to IDH1/2 mutation-induced methylation changes, with some regions being resistant.
• Hypomethylated enhancers were associated with tissue differentiation and cell fate determination.

Conclusions:

• IDH1/2 mutations exert differential effects on DNA methylation across various genomic regions.
• The observed methylation changes suggest distinct regulatory mechanisms influencing different parts of the genome in IDH1/2 mutant cancers.
• These findings contribute to understanding the epigenetic landscape of IDH1/2-driven tumorigenesis.